In a 15‑year‑old female with post‑traumatic stress disorder who is taking acyclovir 400 mg daily and melatonin 5 mg at bedtime, why is the melatonin ineffective and how should her sleep be managed?

Melatonin is likely ineffective in this adolescent with PTSD because it is being used to treat PTSD-related sleep disturbance (likely nightmares or hyperarousal) rather than a circadian rhythm disorder, and the underlying PTSD symptoms require specific trauma-focused treatment.

Why Melatonin Isn't Working

The core issue is that PTSD-related sleep disturbance is fundamentally different from primary insomnia. In PTSD, sleep problems stem from hyperarousal, intrusive nightmares, and fear of sleep itself—not from circadian misalignment 1. Melatonin has only modest effects on sleep latency and minimal impact on sleep continuity in general insomnia 2, and there is no high-quality evidence supporting its use specifically for PTSD-related sleep disturbance in adolescents.

Key factors contributing to melatonin failure:

• Wrong target: PTSD sleep disturbance involves hyperarousal and nightmares (intrusive/re-experiencing symptoms), not circadian dysregulation 1
• Dose may be inappropriate: The 5mg dose is supraphysiological; melatonin acts primarily as a chronobiotic where timing matters more than dose 3
• Timing may be wrong: Without knowing when it's administered relative to her natural sleep phase, it may be mistimed
• Underlying pathology untreated: The PTSD itself is driving the sleep disturbance 1

Recommended Management Approach

First-Line: Trauma-Focused Psychotherapy

Image Rehearsal Therapy (IRT) is the recommended treatment for PTSD-related nightmares and sleep disturbance 4. This is a Level A recommendation for nightmare disorder associated with PTSD. IRT involves:

• Recalling the nightmare
• Rewriting it with a more positive outcome
• Rehearsing the new version 10-20 minutes daily while awake
• This provides cognitive restructuring that empirically refutes the nightmare premise 4

Alternative evidence-based psychotherapies include:

• Cognitive Processing Therapy
• Prolonged Exposure Therapy
• Eye Movement Desensitization and Reprocessing (EMDR)

These are strongly recommended (Level A) over pharmacotherapy for PTSD 5.

Pharmacotherapy Considerations (If Psychotherapy Insufficient)

For PTSD-associated nightmares specifically:

• Prazosin is the only medication with Level A evidence for PTSD-associated nightmares in adults 4. However, pediatric data is limited. Typical dosing starts at 1mg at bedtime, titrated by 1-2mg every few days to effect (average 3mg, range 1-10mg+) 4
• Monitor for orthostatic hypotension

For general PTSD treatment in adolescents:

• SSRIs (sertraline, paroxetine) or SNRIs (venlafaxine) are recommended for overall PTSD symptoms 5
• These may secondarily improve sleep by treating underlying PTSD

What NOT to use:

• Benzodiazepines: Strong recommendation AGAINST use in PTSD 5
• Cannabis/cannabis-derived products: Strong recommendation AGAINST 5
• Melatonin: Insufficient evidence for PTSD-related sleep disturbance; may facilitate fear extinction in preclinical models 6 but lacks clinical trial support in this population

Practical Algorithm

1. Assess the specific sleep complaint:

   • Nightmares/distressing dreams → IRT is first-line 4
   • Sleep-onset insomnia with bedtime anxiety/fear of sleep → Trauma-focused CBT 1
   • Both → Combined IRT + CBT for insomnia

2. Implement sleep hygiene (though this alone is insufficient for PTSD):

   • Consistent sleep schedule
   • Reduce blue light exposure at night
   • Address safety concerns in bedroom environment

3. If psychotherapy is declined, unavailable, or insufficient:

   • Consider prazosin for nightmares (off-label in adolescents; requires informed consent and monitoring)
   • Consider SSRI/SNRI for overall PTSD symptoms with secondary sleep benefit

4. Discontinue melatonin unless there is evidence of a comorbid circadian rhythm disorder (e.g., delayed sleep-wake phase disorder), which would require:

   • Sleep diary/actigraphy to document circadian pattern
   • Lower physiological doses (0.5-1mg)
   • Precise timing 4-6 hours before natural sleep onset

Critical Pitfalls to Avoid

• Misdiagnosing PTSD-related sleep disturbance as primary insomnia: This leads to ineffective symptomatic treatment that doesn't address the underlying trauma 1
• Using melatonin reflexively at bedtime: This ignores its chronobiotic mechanism and appropriate timing requirements 3
• Prescribing benzodiazepines: These are contraindicated in PTSD and may worsen outcomes 5
• Delaying trauma-focused treatment: Psychotherapy is more effective than pharmacotherapy for PTSD and should not be deferred 5

Special Considerations for This Patient

The acyclovir 400mg daily is not contributing to sleep disturbance 7. This is a standard suppressive dose for recurrent herpes infections and has no known sleep-related side effects.

Age-specific factors:

• At 15 years, she may have a natural tendency toward delayed sleep phase (common in adolescence)
• However, if the sleep complaint is specifically nightmares or fear-based insomnia, this points to PTSD pathology rather than developmental circadian shift
• Trauma-focused psychotherapy is safe and effective in adolescents 8

Bottom line: Stop the melatonin, refer for trauma-focused psychotherapy (specifically IRT for nightmares), and consider prazosin or SSRI/SNRI only if psychotherapy is insufficient or unavailable. The sleep disturbance will not resolve without addressing the underlying PTSD 1.